I made a stock purchase this past trading week that I’d like to update you on.  While small, the purchase allowed me to continue growing my Portfolio… one transaction at a time.

With this purchase I continued to build out a Healthcare position that I started last November.  Since then, I’ve added to the position 6 times, with the latest being the one from this week.

The stock has been drifting down in price rather noticeably since the beginning of August and has reached a new 52-week low.  Adding a few shares seemed appropriate considering that it’s a Portfolio position that I’d like to be bigger.

Let’s get to it.  Here are my purchase details…

 

Amgen (AMGN)

Here’s a look at how Amgen’s price has moved over the past year.  My purchase points over that time period are noted by the green arrows.  These reflect the purchase that established my position in November of last year, and the 6 add-on purchases I previously mentioned.

Since late July to today, you can see that AMGN has fallen from a little under $250 to around $209, which is about a 16% decline.

 

 

AMGN is just one of my Healthcare stocks that looks attractively valued these days.  I chose to add to AMGN at this time since I’ve added more heavily to Merck & Co. (MRK) and Bristol-Myers Squibb (BMY) in recent months.

On 10/7/21, I bought 3 shares at $209.20 for a total of $627.60.  This boosted my AMGN position by approximately 18.5%.

The stock yielded 3.37% at my purchase price (almost 1% percent greater than my current Portfolio average of 2.40%).

I now own 19.192 shares of AMGN.  This latest purchase was my least expensive AMGN purchase yet.  It lowered my cost basis to $222.33/share.

This purchase also boosted my annual forward dividend income by $21.12.

AMGN should announce a dividend raise in December if past history is any indication.  This will provide another way for my AMGN dividend to increase.

AMGN was able to move up one spot with respect to my Portfolio value.  Its ranking sits behind The Walt Disney Co. (DIS), but ahead of OGE Energy (OGE).  However, it still remains as the 9th smallest position in my Portfolio, with a current value of $4,010.17.

With AMGN already a part of my Portfolio prior to this purchase, the number of stocks in my Portfolio remained at 54.

 

Summary

The dividend weighting of my Healthcare sector holdings only got stronger after another addition in that group.

Good values appear to exist in many Healthcare stocks and I’ve been adding to a few names in recent months, including this week.  This time around I scooped up a few more shares of AMGN at my lowest price yet.

The purchase resulted in a net investment of $627.60 into my Portfolio, and my forward dividend income increased by $21.12.

 

What existing positions have you been adding to lately?  Does AMGN look enticing to you at current levels?  Please share in the comments!